loader from loading.io

Trends in Emergent Interfacility Ischemic Stroke Transfers

Neurology Minute

Release Date: 10/30/2026

Youth Football and the Epidemic of Pediatric Brain Injury - Part 1 show art Youth Football and the Epidemic of Pediatric Brain Injury - Part 1

Neurology Minute

In part one of this series, Dr. Dara Albert and Isaac Thorman discuss football as a major contributor to pediatric traumatic brain injury and its association with subsequent head injuries.  Show citation:  Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi: 

info_outline
Acute Optic Neuropathy in Older Adults show art Acute Optic Neuropathy in Older Adults

Neurology Minute

Dr. Justin Abbatemarco discusses an article that helps us distinguish between the causes of acute optic neuropathy.  Show citation:  Tisavipat N, Stiebel-Kalish H, Palevski D, et al. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024;11(3):e200214. doi:

info_outline
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis show art Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis

Neurology Minute

Dr. Aaron Zelikovich discusses how gefurulimab may offer an effective and convenient treatment option for adults with generalized myasthenia gravis. Show citation: Gwathmey KG, SaccĂ  F, Howard JF Jr, et al. Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. JAMA Neurol. 2026;83(9):841-850. doi: 

info_outline
Trends in Emergent Interfacility Ischemic Stroke Transfers show art Trends in Emergent Interfacility Ischemic Stroke Transfers

Neurology Minute

Dr. Andy Southerland and Dr. Matthew Gusler discuss how emergent interfacility transfers for ischemic stroke have changed and the factors associated with which patients are transferred.  Show citation: Gusler MT, Deligkaris C, Zha AM, Burke JF. Trends in Emergent Interfacility Ischemic Stroke Transfers, 2016-2022. Neurology. 2026;107(7):e218499. doi:

info_outline
Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS show art Clinical Reasoning: Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia in a Patient With MS

Neurology Minute

Dr. Zohaib Siddiqi and Dr. Michel Toledano discuss the diagnosis and management of infectious rhombencephalitis in patients receiving immunomodulatory therapy. Show citation: Trentadue T, Martinez Sosa S, Itoh CY, et al. Clinical Reasoning: A 30-Year-Old Female Patient With Multiple Sclerosis Presenting With Rapidly Progressive Cranial Neuropathies, Weakness, and Ataxia. Neurology. 2025;105(12):e214429. doi: 

info_outline
Optimizing Management of Episodic Cluster Headache show art Optimizing Management of Episodic Cluster Headache

Neurology Minute

Dr. Tesha Monteith shares practical tips for improving outcomes for patients with episodic cluster headache.

info_outline
Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine show art Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Adults with Migraine

Neurology Minute

Dr. Tesha Monteith discusses growing evidence supporting CGRP-targeted therapies as first-line preventive treatment options for people with migraine. Show citation:  Reuter U, Dycke AV, Versijpt J, et al. Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial. Lancet Neurol. 2026;25(9):806-817. doi: 

info_outline
Rethinking Seronegative NMOSD show art Rethinking Seronegative NMOSD

Neurology Minute

Dr. Casey Kozak discusses why most patients referred with seronegative NMOSD ultimately receive alternative diagnoses, underscoring the challenges of accurate diagnosis in antibody-negative cases.  Show citation: Lang MV, Welk GM, Tajfirouz DA, et al. Unveiling Misdiagnosis: Rethinking Seronegative NMOSD. Mult Scler. 2025;31(11):1381-1384. doi: 

info_outline
The Menopause Transition and Epilepsy show art The Menopause Transition and Epilepsy

Neurology Minute

Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation:  Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:

info_outline
The Menopause Transition and Epilepsy show art The Menopause Transition and Epilepsy

Neurology Minute

Dr. Katie Krulisky and Dr. Kelsey Smith discuss the impact of menopause on women with epilepsy, including therapeutics and clinical management during midlife. Show citation:  Smith KM, Faubion SS, Vadlamudi L, et al. The Menopause Transition and Epilepsy: A Focus on Therapeutics. Neurol Clin Pract. 2026;16(5):e200650. doi:

info_outline
 
More Episodes

Dr. Andy Southerland and Dr. Matthew Gusler discuss how emergent interfacility transfers for ischemic stroke have changed and the factors associated with which patients are transferred. 

Show citation:

Gusler MT, Deligkaris C, Zha AM, Burke JF. Trends in Emergent Interfacility Ischemic Stroke Transfers, 2016-2022. Neurology. 2026;107(7):e218499. doi:10.1212/WNL.0000000000218499